ASRT's earnings surpassed estimates in each of the trailing four quarters, the average beat being 179.78%. The company delivered an earnings surprise of 482.61% in the last reported quarter.

ASRT currently has a forward P/E ratio of 6.99, while ZTS has a forward P/E of 34.53. We also note that ASRT has a PEG ratio of 0.70. This popular figure is similar to the widely-used P/E ratio ...

Analysts estimate that Assertio Holdings will report an earnings per share (EPS) of $-0.04. Assertio Holdings bulls will hope to hear the company announce they've not only beaten that estimate, but ...

Based on the latest available data, ASRT has gained about 42.7% so far this year. In comparison, Medical companies have returned an average of -10.3%.

ASRT stock is down 39.4% as of Thursday morning with some 678,000 shares changing hands. To put that in perspective, the company’s daily average trading volume is closer to 1.5 million shares.

Assertio Therapeutics, Inc. (NASDAQ: ASRT) was in 14 hedge funds’ portfolios at the end of March. ASRT has experienced a decrease in hedge fund interest of late. There were 16 hedge funds in our ...

Read More on ASRT: Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635 (c) (4) Assertio Holdings sees FY23 product sales $150M-$160M, consensus $154.61M ...